Introduction:
Oligo Factory, a company that manufactures oligonucleotides at scale, has achieved compliance with current Good Manufacturing Practices (GMP). This achievement highlights the company’s commitment to quality control and adherence to strict global regulatory standards. The CEO of Oligo Factory, Chris Boggess, expressed his pride in the team’s efforts to reach this milestone.
- Oligo Factory has achieved GMP ICHQ7 compliance, which is a critical benchmark for the pharmaceutical and biotechnology industries.
- The company has implemented a comprehensive quality management system to align its operations with GMP guidelines. This includes enhanced documentation and traceability practices, rigorous training programs, regular audits, and continuous improvement initiatives.
- GMP compliance allows Oligo Factory to improve the quality and consistency of its oligonucleotide products, which are used in drug discovery, therapeutic development, and diagnostic testing.
- Last year, the company opened a new synthesis facility in Holliston, MA, which increased its synthesis capacity and purification capabilities.
Conclusion:
Oligo Factory’s achievement of GMP compliance demonstrates its commitment to producing high-quality oligonucleotides and meeting global regulatory standards. This milestone allows the company to better serve its customers and enhance the quality and consistency of its products. Oligo Factory’s dedication to continuous improvement and adherence to GMP guidelines position it as a leader in the manufacturing of oligonucleotides.
